{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:06:43Z","timestamp":1779930403811,"version":"3.53.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Foundation For Youth Entrepreneurship And Employment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04801-y","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:22:50Z","timestamp":1776442970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interstitial lung disease during paclitaxel trastuzumab therapy enables safe trastuzumab rechallenge: a case report and review of the literature"],"prefix":"10.1007","volume":"17","author":[{"given":"Zhaojun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianye","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"20","key":"4801_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMoa1406281","volume":"373","author":"SM Tolaney","year":"2015","unstructured":"Tolaney SM, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015;373(20):1989. https:\/\/doi.org\/10.1056\/NEJMoa1406281.","journal-title":"N Engl J Med"},{"issue":"1","key":"4801_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000326063","volume":"4","author":"O Abulkhair","year":"2011","unstructured":"Abulkhair O, El Melouk W. Delayed paclitaxel-trastuzumab-induced interstitial pneumonitis in breast cancer. Case Rep Oncol. 2011;4(1):186\u201391. https:\/\/doi.org\/10.1159\/000326063.","journal-title":"Case Rep Oncol"},{"issue":"5","key":"4801_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/jcpt.13118","volume":"45","author":"Z Ye","year":"2020","unstructured":"Ye Z, Chen J, Chen M, Wu J. Is the interstitial lung disease induced by trastuzumab? Case report and literature review. J Clin Pharm Ther. 2020;45(5):1183\u20136. https:\/\/doi.org\/10.1111\/jcpt.13118.","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"4801_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5339\/qmj.2024.qitc.12","volume":"2024","author":"MA Al-Tikrity","year":"2024","unstructured":"Al-Tikrity MA, El Tahir OS, Gaber M, Suliman AM, Hussain A. Trastuzumab\/paclitaxel-induced pneumonitis in breast cancer. Qatar Med J. 2024;2024(2):12. https:\/\/doi.org\/10.5339\/qmj.2024.qitc.12.","journal-title":"Qatar Med J"},{"issue":"2","key":"4801_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1378\/chest.07-0851","volume":"133","author":"B Vahid","year":"2008","unstructured":"Vahid B, Marik PE. Pulmonary complications of novel antineoplastic agents for solid tumors. Chest. 2008;133(2):528\u201338. https:\/\/doi.org\/10.1378\/chest.07-0851.","journal-title":"Chest"},{"issue":"2","key":"4801_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12282-014-0564-9","volume":"23","author":"IA Santana","year":"2016","unstructured":"Santana IA, Oliveira J, da Silva Lima JM, Testa L, Piato JRM, Hoff PM, et al. Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting. Breast Cancer. 2016;23(2):261\u20135. https:\/\/doi.org\/10.1007\/s12282-014-0564-9.","journal-title":"Breast Cancer"},{"key":"4801_CR7","doi-asserted-by":"publisher","first-page":"701424","DOI":"10.3389\/fonc.2021.701424","volume":"11","author":"L Ardolino","year":"2021","unstructured":"Ardolino L, Lau B, Wilson I, Chen J, Borella L, Stone E, et al. Case report: paclitaxel-induced pneumonitis in early breast cancer: a single institution experience and review. Front Oncol. 2021;11:701424. https:\/\/doi.org\/10.3389\/fonc.2021.701424.","journal-title":"Front Oncol"},{"issue":"12","key":"4801_CR8","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1080\/14737140.2021.1996229","volume":"21","author":"S Chen","year":"2021","unstructured":"Chen S, Ruan Y, Dai H, Li Y, Lan B, Ma F. Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review. Expert Rev Anticancer Ther. 2021;21(12):1399\u2013410. https:\/\/doi.org\/10.1080\/14737140.2021.1996229.","journal-title":"Expert Rev Anticancer Ther"},{"key":"4801_CR9","doi-asserted-by":"publisher","first-page":"12977","DOI":"10.1038\/srep12977","volume":"5","author":"WJ Liu","year":"2015","unstructured":"Liu WJ, Zhong ZJ, Cao LH, Li HT, Zhang TH, Lin WQ. Paclitaxel-induced lung injury and its amelioration by parecoxib sodium. Sci Rep. 2015;5:12977. https:\/\/doi.org\/10.1038\/srep12977.","journal-title":"Sci Rep"},{"key":"4801_CR10","doi-asserted-by":"publisher","first-page":"152231","DOI":"10.1016\/j.tox.2019.06.002","volume":"424","author":"M Kawami","year":"2019","unstructured":"Kawami M, Hirai T, Ojima T, Yamagami Y, Yumoto R, Takano M. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells. Toxicology. 2019;424:152231. https:\/\/doi.org\/10.1016\/j.tox.2019.06.002.","journal-title":"Toxicology"},{"issue":"10","key":"4801_CR11","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1200\/JCO.2005.01.014","volume":"23","author":"J Baselga","year":"2005","unstructured":"Baselga J, Carbonell X, Casta\u00f1eda-Soto NJ, Clemens M, Green M, Harvey V, et al. Phase II study of efficacy, safety and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule. J Clin Oncol. 2005;23(10):2162\u201371. https:\/\/doi.org\/10.1200\/JCO.2005.01.014.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4801_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/jcrt.JCRT_1225_16","volume":"17","author":"R Raghupathi","year":"2021","unstructured":"Raghupathi R, Prabhu C, Dhiman P. Drug-induced infiltrative lung disease with weekly paclitaxel in breast cancer: case series. J Cancer Res Ther. 2021;17(1):262\u20135. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1225_16.","journal-title":"J Cancer Res Ther"},{"key":"4801_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04801-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04801-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:41:18Z","timestamp":1779928878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04801-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4801"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04801-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The Ethics Committee of Wenzhou Central Hospital approved the study protocol (Approval Number: 202205182247000594327). Written informed consent for publication of this case report, including anonymized clinical data and images, was obtained from the patient. The signed consent form is retained by the Ethics Committee of Wenzhou Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"810"}}